Related Experiment Video
Updated: Jan 16, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Antioxidant and anticancer properties of citrus-mediated nanoformulations revealed by meta-analysis
Rahmat Budiarto1, Mohammad Miftakhus Sholikin2, Danung Nur Adli3
1Department of Agronomy, Faculty of Agriculture, Universitas Padjadjaran, Sumedang, 45363, Indonesia. rahmat.budiarto@unpad.ac.id.
Abstract:
This study aims to explore and analyse the potential antioxidant and anticancer potential of various citrus-mediated nanoformulations (CMNs), focusing on their effectiveness in scavenging free radicals and inducing cytotoxicity in cancer cells. This research employs a meta-analysis approach to assess data from multiple studies on CMNs. This study is the first meta-analysis to evaluate the antioxidant and anticancer properties of CMNs concurrently. This study offers a novel perspective by examining citrus species, plant parts utilised, nanoparticle types, particle sizes, and coating materials. The analysis employs the Population, Intervention, Comparison, and Outcome (PICO) framework and complies with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The analysis utilizes Hedges' effect size and includes validation through fail-safe N. The IC50 evaluation (µg/mL) revealed a significant effect of CMNs on antioxidant activity (d++ = 3.49; P < 0.05). The IC50 value of 3.49 in the CMN indicates that a lower concentration is sufficient to inhibit 50% of the free radical activity, reflecting a stronger antioxidant potential than that of the control group. However, the overall antioxidant assay results (d++ = 0.2; P = 0.309) and radical inhibition (%) for CMNs (d++ = 0.1; P = 0.602) did not significantly differ. Subgroup analysis provided further insights, showing that both citrus peel and polyvinyl alcohol significantly reduced IC50 values (d++ >1; P < 0.05). In addition, radical inhibition significantly increased in CMNs derived from Citrus paradisi (d++ = 3.05; P = 0.015), followed by those derived from Citrus limon (d++ = 2.25; P < 0.01) and Citrus reticulata (d++ = 1.03; P = 0.025). Various types of nanoformulations, such as Ag chitosan-NP (silver nanoparticle with chitosan), Ag-NP (silver nanoparticles), cerium dioxide nanoparticle (CeO₂-NPs), hydrogel-based nanocomposite (Hydrogel-NPCs), pectin-based nanoemulsion (Pectin-NPEs), titanium dioxide nanoparticle (TiO₂-NP), and whey-based nanoemulsion (Whey-NPEs), also significantly enhanced free radical scavenging activity (d++ >1; P < 0.01). In terms of anticancer activity, CMN has a strong effect size (|d++| >1; P < 0.05), with species such as Citrus macroptera and plant parts such as juice showing highly positive effects (d++ = 2.25; P < 0.001). Additionally, nanoparticles with sizes between 101 and 500 nm exhibited significant effectiveness (d++ = 2.26; P < 0.001). These findings indicate that citrus-derived compounds have potential as anticancer agents by actively enhancing the antioxidant capacity of healthy cells. The significant antiproliferative activity observed across multiple cancer cell lines, supported by robust statistical analyses, demonstrates the potential of CMNs as a natural therapeutic approach for cancer prevention and treatment.
Insights
This meta-analysis reveals that citrus-mediated nanoformulations (CMNs) show significant antioxidant and anticancer potential. Specific citrus species, plant parts, and nanoparticle types enhance these therapeutic effects, suggesting CMNs as promising natural agents for cancer treatment.
Area of Science:
- Nanomedicine and Drug Delivery
- Natural Product Chemistry
- Oncology and Cancer Therapeutics
Background:
- Citrus-mediated nanoformulations (CMNs) are emerging as potential therapeutic agents.
- Existing research on their antioxidant and anticancer properties is fragmented.
- A comprehensive evaluation of CMNs' dual potential is lacking.
Purpose of the Study:
- To conduct the first meta-analysis evaluating both antioxidant and anticancer properties of CMNs concurrently.
- To analyze the influence of citrus species, plant parts, nanoparticle types, sizes, and coating materials on CMN efficacy.
- To assess the free radical scavenging and cytotoxic effects of CMNs.
Main Methods:
- Meta-analysis adhering to PRISMA guidelines.
- Population, Intervention, Comparison, and Outcome (PICO) framework utilized.
- Hedges' effect size calculated for antioxidant and anticancer activities, with fail-safe N validation.
Main Results:
- CMNs demonstrated a significant effect on antioxidant activity (IC50, d++ = 3.49, P < 0.05).
- Citrus peel and polyvinyl alcohol significantly reduced IC50 values (d++ > 1, P < 0.05).
- Anticancer activity was significant (|d++| > 1, P < 0.05), with notable effects from Citrus macroptera juice and nanoparticles sized 101-500 nm.
Conclusions:
- CMNs exhibit significant potential as antioxidant and anticancer agents.
- Specific parameters like citrus source, plant part, and nanoparticle characteristics influence efficacy.
- CMNs represent a promising natural therapeutic strategy for cancer prevention and treatment.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Related Concept Videos
Cancer Prevention
Some...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...